Search Results
Oct 31, 2025, 08:00 ET Alpha Fusion Initiates Company-Sponsored Clinical Trial of Alpha-Emitting Radiopharmaceutical af-001 in Patients with Differentiated Thyroid Cancer
First-in-Human Study of [211At]NaAt as Targeted Alpha Therapy in Patients with Radioiodine-Refractory Thyroid Cancer (Alpha-T1 Trial).J Nucl Med. September 25, 2025.) The present company-sponsored trial aims to evaluate the efficacy and safety of af-001 (identical
More news about: Alpha Fusion Inc
Oct 30, 2025, 11:00 ET Clinical Late-Breaking Abstracts Announced for the Society for Immunotherapy of Cancer's 40th Anniversary Annual Meeting
the safety, pharmacokinetics, pharmacodynamics and initial efficacy of mRNA-LNP MT-302 in vivo CAR therapy in solid tumors Rasha Cosman, BSc (Med), MBBS, FRACP – St. Vincent's HospitalSession 104: Clinical Oral Abstract Session – Friday, Nov. 7, 2025 – 11:30 a.m. ET
More news about: Society for Immunotherapy of Cancer (SITC)
Oct 30, 2025, 07:00 ET Coro Medical and PulsePoint Partner to Donate 10 Lifesaving AED Packages During Sudden Cardiac Arrest Awareness Month
https://www.prnewswire.com/news-releases/coro-medical-and-pulsepoint-partner-to-donate-10-lifesaving-aed-packages-during-sudden-cardiac-arrest-awareness-month-302599257.html SOURCE Coro Med
More news about: Coro Med
Oct 30, 2025, 06:43 ET Breckenridge announces launch of Everolimus Tablets, 1mg, generic version of Zortress®
bottles launched in June 2023. We continue to focus on the development of therapies that provide affordable access to all patients and address unmet med ical needs," states Brian Guy, President and CCO of Breckenridge Pharmaceutical, Inc. *Please
More news about: Breckenridge Pharmaceutical, Inc.
Oct 29, 2025, 14:00 ET Hansa hosts call with distinguished transplant surgeons: Insights on clinical practice and imlifidase Phase 3 Results
on_en.pdf. 9_Jordan SC, et al. IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation. N Engl J Med 2017;377:442-453. DOI: 10.1056/NEJMoa16125 10_Winstedt L, et al. Complete Removal of Extracellular IgG Antibodies in a Randomized
More news about: Hansa Biopharma AB
Oct 29, 2025, 13:57 ET Hansa hosts call with distinguished transplant surgeons: Insights on clinical practice and imlifidase Phase 3 Results
on_en.pdf. 9_Jordan SC, et al. IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation. N Engl J Med 2017;377:442-453. DOI: 10.1056/NEJMoa16125 10_Winstedt L, et al. Complete Removal of Extracellular IgG Antibodies in a Randomized
More news about: Hansa Biopharma AB
Oct 29, 2025, 08:48 ET From Exam Room to Courtroom: Med Legal Pro's Tracy Liberatore Launches New Podcast "Statutes & Stethoscopes"
compelling new podcast has entered the med-legal space. Statutes & Stethoscopes, hosted by physician assistant–turned–trial attorney Tracy Liberatore, dives deep into the high-stakes intersection of clinical care and courtroom advocacy. Produced by Med Legal Pro, this bi-weekly series dissects
More news about: Med Legal Pro, LLC
Oct 29, 2025, 03:49 ET İTALYA, ECOMONDO 2025, KÜRESEL ARAŞTIRMA VE İNOVASYON MERKEZİ
oturumla ilk kez uluslararası bir izleyici kitlesine açılacak. Ecomondo, Meksika ve Çin'deki edisyonları, Napoli'deki Green Med Sempozyumu ve Kahire, Belgrad ve Varşova'da durakları olan 2025 roadshow'u içeren küresel bir ağın parçasıdır. Münih ve Roma'dan
More news about: Italian Exhibition Group
Oct 28, 2025, 21:23 ET VUNO Partners with European Firms to Advance DeepCARS® Market Entry in Europe
VUNO Med ® -DeepCARS ® VUNO Med®-DeepCARS®(DeepCARS) is an
More news about: VUNO
Oct 28, 2025, 21:14 ET VUNO Partners with European Firms to Advance DeepCARS® Market Entry in Europe
VUNO Med ® -DeepCARS ® VUNO Med®-DeepCARS®(DeepCARS) is an
More news about: VUNO
Oct 28, 2025, 18:36 ET U.S. Centers for Medicare & Medicaid Services finalizes National Coverage Determination for the Medtronic Symplicity Spyral™ renal denervation (RDN) system
7;82(19):1809-1823.5Böhm M, Kario K, Kandzari DE, et al. Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. Lancet. 2020 May 2;395(10234):1444-1451. 6 Kario K, Ogawa H, Okumura
More news about: Medtronic plc
Oct 28, 2025, 11:18 ET Italia, Ecomomdo 2025, centro global de investigación e innovación
políticos y empresas extranjeras. Ecomondo forma parte de una red global que incluye ediciones en México y China, el Simposio Green Med en Nápoles y una gira itinerante en 2025 con escalas en El Cairo, Belgrado y Varsovia. Se programan vuelos chárter desde Múnich
More news about: Italian Exhibition Group
Oct 28, 2025, 11:06 ET ITALIE, ECOMONDO 2025, PÔLE MONDIAL DE RECHERCHE ET D'INNOVATION
entreprises étrangères. Ecomondo fait partie d'un réseau mondial qui comprend des éditions au Mexique et en Chine, le symposium Green Med à Naples et un roadshow 2025 qui s'est arrêté au Caire, à Belgrade et à Varsovie. Des vols charters sont prévus au départ de Munich
More news about: Italian Exhibition Group
Oct 28, 2025, 10:38 ET ITALIEN, ECOMONDO 2025, GLOBALES ZENTRUM FÜR FORSCHUNG UND INNOVATION
ausländischen Unternehmen zu erweitern. Ecomondo ist Teil eines globalen Netzwerks, zu dem Ausgaben in Mexiko und China, das Green Med Symposium in Neapel und eine Roadshow 2025 gehören, die in Kairo, Belgrad und Warschau Station machte. Charterflüge werden von
More news about: Italian Exhibition Group
Oct 28, 2025, 10:05 ET Distinguished Family Physician Gaddiel Rios, M.D., Opens First MDVIP-Affiliated Practice in South Dakota in Partnership with Monument Health
Gaddiel D. Rios, M.D., in partnership with MED 360 by Monument Health. Dr. Rios, a former U.S. Army doctor with 22 years of experience in family medicine, is accepting new patients at his clinic,
More news about: MDVIP
Oct 28, 2025, 09:33 ET 在世界皮膚健康日，CeraVe 支持全球皮膚健康領袖向弱勢患者提供護理
Rosenbaum BE et al. Pan Afr Med J. 2017;26:125.3
More news about: CeraVe
Oct 28, 2025, 09:33 ET CeraVeは、世界スキン・ヘルス・デイ（World Skin Health Day）に、十分なケアを受けられていない患者にケアを提供するために、世界のスキン・ヘルス分野のリーダーを支援します
Pan Afr Med J. 2017;26:125. 3
More news about: CeraVe
Oct 28, 2025, 09:33 ET 세라비, 세계 피부건강의 날 맞아 피부건강 분야 글로벌 리더들과 소외환자 위한 피부과 진료 지원
Pan Afr Med J. 2017;26:125.3
More news about: CeraVe
Oct 28, 2025, 09:33 ET CeraVe podporuje globálnych lídrov v oblasti zdravia pokožky pri poskytovaní starostlivosti znevýhodneným pacientom počas Svetového dňa zdravia pokožky
Rosenbaum BE a kol. Pan Afr Med J. 2017;26:125.3
More news about: CeraVe
Oct 28, 2025, 09:33 ET CeraVe Supports Global Skin Health Leaders to Deliver Care to Underserved Patients on World Skin Health Day
Rosenbaum BE et al. Pan Afr Med J. 2017;26:125.3
More news about: CeraVe
Oct 28, 2025, 09:33 ET W Światowym Dniu Zdrowia Skóry firma CeraVe wspiera światowych liderów w dziedzinie zdrowia skóry, oferując opiekę pacjentom z obszarów o ograniczonym dostępie do usług medycznych
Rosenbaum BE et al. Pan Afr Med J. 2017;26:125.[3]
More news about: CeraVe
Oct 28, 2025, 09:33 ET CeraVe Supports Global Skin Health Leaders to Deliver Care to Underserved Patients on World Skin Health Day
Rosenbaum BE et al. Pan Afr Med J. 2017;26:125.3
More news about: CeraVe
Oct 28, 2025, 09:33 ET CeraVe поддерживает мировых лидеров в области здоровья кожи и оказывает помощь пациентам из малообеспеченных регионов во Всемирный день здоровья кожи
Rosenbaum BE et al. Pan Afr Med J. 2017;26:125.3
More news about: CeraVe
Oct 28, 2025, 09:33 ET CeraVe podporuje světové odborníky v oblasti péče o pleť při poskytování péče znevýhodněným pacientům u příležitosti Světového dne zdraví pokožky
Rosenbaum BE a kol. Pan Afr Med J. 2017;26:125.3
More news about: CeraVe
Oct 28, 2025, 09:33 ET CeraVe unterstützt am Welt-Hautgesundheitstag weltweit führende Hautarztpraxen bei der Versorgung unterversorgter Patienten
Rosenbaum BE et al. Pan Afr Med J. 2017;26:125.3
More news about: CeraVe